Quest Diagnostics Data License (CSELS) Cost Share

The contract involves Quest Diagnostics Incorporated providing annual data submissions related to drug testing under the administrative code CPNED within the Partnerships and Evaluation Branch of the Centers for Disease Control and Prevention. The agreement is structured as a cost-sharing data license under the CSELS framework, with the primary focus on the collection and reporting of drug test results to support public health surveillance and evaluation efforts. Performance is tied to the CDC’s objective of monitoring substance use trends through standardized, centralized data reporting, with the scope encompassing technical compliance, data accuracy, and timely delivery per established protocols. The contracting entity is the Centers for Disease Control and Prevention, with Charla Jackson identified as the program point of contact and the contracting officer position listed as to be determined. Although the solicitation number and specific financial details are not provided, the contract falls under the NAICS code 541512, indicating it pertains to custom computer programming services, likely related to data integration and secure reporting systems. The forecast was posted on May 25, 2026, signaling anticipated future activity, with no set-aside designation or geographic restrictions specified, allowing for national-scale data collection and analysis.